Fulcrum Therapeutics (FULC) Change in Account Payables (2018 - 2026)
Fulcrum Therapeutics (FULC) has 9 years of Change in Account Payables data on record, last reported at $858000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 150.15% to $858000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $943000.0, a 140.13% increase, with the full-year FY2025 number at $428000.0, up 126.87% from a year prior.
- Change in Account Payables reached $858000.0 in Q1 2026 per FULC's latest filing, up from -$1.1 million in the prior quarter.
- Over the last five years, Change in Account Payables for FULC hit a ceiling of $1.1 million in Q1 2024 and a floor of -$2.7 million in Q4 2024.
- A 5-year average of -$137411.8 and a median of $163000.0 in 2023 define the central range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 1150.0% in 2024 and fell as far as 279.75% in 2024.
- Tracing FULC's Change in Account Payables over 5 years: stood at $903000.0 in 2022, then crashed by 190.48% to -$817000.0 in 2023, then plummeted by 230.11% to -$2.7 million in 2024, then skyrocketed by 59.03% to -$1.1 million in 2025, then surged by 177.65% to $858000.0 in 2026.
- Business Quant data shows Change in Account Payables for FULC at $858000.0 in Q1 2026, -$1.1 million in Q4 2025, and $946000.0 in Q3 2025.